Pharma Stocks

Trump Announces 25% Tariff On Auto Imports, Chips And Pharmaceuticals, Shaking Global Trade: Nvidia, Apple, TSMC And Others In Focus
Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial
4 months ago
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
8 months ago
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
10 months ago
Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets
10 months ago

Pharma Stocks Recent News

Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda
Pharmaceutical company Merck & Company (NYSE: MRK) reports second quarter financial results before market open Tuesday.
Jul 31, 2023, 4:34 PM
|
Mark Cuban Helping Lower Cost Of Bestselling Humira With Cost Plus Drug Company: 'The Game Just Changed'
One of the bestselling medical drugs of all time has come off patent. The result could mean lower costs for those who need the drug as a treatment option. Enter Mark Cuban and his Cost Plus Drug Company, which announced a new initiative Thursday.
Jun 1, 2023, 6:13 PM
|
Jim Cramer Hates Being 'Downbeat,' But Warns: Default On Debt Would Affect Geopolitical Face Of US
May 12, 2023, 5:29 AM
|
6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative'
Rocket Pharma (NASDAQ: RCKT) CEO Gaurav Shah is on a mission to "change the narrative" when it comes to rare diseases.
Apr 7, 2023, 5:50 PM
|
Jim Simons 'The Man Who Solved The Market' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
Jim Simons is the founder and hedge fund manager of Renaissance Technologies, which currently has a total portfolio value north of $77 billion, per Stock Circle. This hedge fund uses a quantitative strategy in determining its stock trades.
Nov 20, 2022, 1:48 PM
|
Microvast, AMC, Moderna, Clover Health, Pfizer, And More — Stocks Buzzing On WallStreetBets Today
Microvast Holdings Inc. (NASDAQ: MVST) remains the most-discussed stock on Reddit’s r/WallStreetBets forum as of Tuesday night, while AMC Entertainment Holdings Inc. (NYSE: AMC), Moderna Inc. (NASDAQ:
Aug 11, 2021, 4:54 AM
|
What's Up With Novavax Stock?
Novavax, Inc (NASDAQ: NVAX) shares closed 12.24% higher in the regular session on Monday. What Happened: The biotechnology company working on a COVID-19 vaccine saw its shares move 0.74% higher in the after-hours trading.
Aug 10, 2021, 3:35 AM
|
Moderna Is Now Valued Higher Than 130-Year Old Vaccine Giant Merck
Moderna Inc (NASDAQ: MRNA), a company founded in 2010, is now worth more than the 130-year old Merck & Co., Inc (NYSE: MRK) in terms of market capitalization.
Aug 10, 2021, 2:38 AM
|
CVS, Walgreens, Rite Aid Shares Fall On Report Of Potential Amazon Entry Into Retail Pharmacy
CVS (NYSE: CVS), Walgreens (NASDAQ: WBA) and Rite Aid (NYSE: RAD) shares lost ground Wednesday after a 
May 26, 2021, 8:28 PM
|
Private Equity EQT Offers To Acquire Swedish Pharma Recipharm For $2.1B
Stockholm headquartered private equity group EQT AB will buy Swedish pharma company Recipharm AB for $2.1 billion, according to company's
Dec 14, 2020, 11:35 AM
|
Pfizer Applies For Emergency Approval For COVID-19 Vaccine In India: Media Reports
Pfizer Inc. (NYSE: PFE) is seeking emergency approval for its COVID-19 vaccine in India, according to media sources in the country.
Dec 6, 2020, 3:03 PM
|
UK To Approve Pfizer-BioNTech Vaccine 'Within Days,' Secures 2M More Doses From Moderna
The U.K.
Nov 29, 2020, 3:10 PM
|
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the Thanksgiving holiday.
Nov 29, 2020, 1:59 PM
|
Pfizer: SEC Foreign-Bribery Unit Has Formally Asked Company For Info
Pfizer Inc. (NYSE: PFE) has disclosed in its earnings report that it received an official request for information from the US Securities and Exchange Commission, according to The Wall S
Nov 8, 2020, 6:15 PM
|
Johnson & Johnson Downplayed Opioid Drugs' Side Effects, New York Unveils Charges
New York Governor Andrew Cuomo on Thursday announced the state has filed civil charges against Johnson & Johnson (NYSE: JNJ), accusing it of insurance fraud in connection with understating the risks posed by opioid drugs to doctors and elderly patients. 
Sep 18, 2020, 2:06 AM
|
Bayer Settles Most Cases Related To Roundup Herbicide For Up To $10.9B
Bayer AG (OTC: BAYRY) will pay between $10.1 to $10.9 billion to resolve litigation over the weedkiller Roundup. 
Jun 25, 2020, 10:01 AM
|
Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July
Johnson & Johnson (NYSE: JNJ) will begin the human clinical trials of its novel coronavirus (COVID-19) vaccine in July, the company announced
Jun 11, 2020, 4:16 AM
|
Novavax Begins Phase 1 Clinical Trial Of Its Coronavirus Vaccine
Novavax Inc. (NASDAQ: NVAX) announced on Monday it had started the first phase of its novel coronavirus (COVID-19) vaccine trials.
May 26, 2020, 6:48 AM
|
Teladoc Narrows Loss In Q1 As Coronavirus Causes Demand Surge For Remote Health Services
Teladoc Health Inc. (NYSE: TDOC) on Wednesday reported that it reduced losses in the first quarter compared to a year ago, as the novel coronavirus (COVID-19) pandemic caused a surge in demand for its services.
Apr 30, 2020, 6:23 AM
|
Novartis' Sandoz To Pay $195M For Price-Fixing
Mar 3, 2020, 4:31 AM
|
New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofA
Feb 10, 2020, 7:43 PM
|
Pharma Companies Shares Tank As Feds Investigate Opioid Crisis
Nov 27, 2019, 11:14 AM
|
Barron's Picks And Pans: Pfizer's New Identity, Electric Vehicles, Hong Kong Exodus — And Is The Bull Market About To End?
Nov 23, 2019, 8:42 PM
|
;

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved